Skip to content
Search

Latest Stories

PDA calls on contractors to support their prov reg pharmacists after assessment results

The Pharmacists' Defence Association (PDA) has urged community pharmacy employers to support their provisionally registered pharmacists once their registration assessment results are announced.

The candidates, who have appeared for the GPhC’s first online assessments on March 17 and 18 March, will receive their results via email by 9 am on April 29.


The latest call by the association follows the General Pharmaceutical Council’s (GPhC) announcement that those who fail to pass their registration assessment will be removed from the 'provisional' list as soon as the exam results are announced.

“The whole cohort and the wider profession will see how employers treat these vulnerable employees at this time. The PDA reiterate the request that employers take every effort to treat all those who do not pass fairly, sensitively and with dignity,” the association said.

“Not just because that is the decent thing for employers to do, but at a time that the role of pharmacists is now on the shortage occupation list, employers should be extremely mindful of the impact their actions will have on their reputation with potential future employees.”

Jasraj Mathura, a provisionally registered pharmacist and PDA Union executive committee member said: “The past 12 months have been extremely challenging for pre-registration pharmacists. Following the GPhC postponement of the initial ‘paper based’ assessment last year there were some of us who took on the new role of provisional registered pharmacist, at the height of the pandemic, and others who were unable to register provisionally, many of whom have supported pharmacy teams across the different sectors. More than two thousand individuals have spent hours revising and sat the GPhC online assessment last month.”

The PDA has said that it will continue to support all members, including student, pre-registration, provisionally registered and pharmacist members, and any potential pharmacists who have not yet passed the assessment but are eligible to sit the assessment in future.

It added that it will be providing advice about the appeals processes for those who wish to consider a challenge to their exam result.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Pharmacy First: Government confirms £215 million boost to realise its full potential

From April 2025, the consultation fee for Pharmacy First Minor Illness and Clinical Pathways will rise from £15 to £17.

‘Pharmacy First hasn't realised its full potential,’ says Stephen Kinnock

Health Minister Stephen Kinnock has acknowledged that Pharmacy First has huge potential, noting that the service “hasn't realised its full potential.”

As part of efforts to enhance the service, Kinnock yesterday (30) announced £215 million in additional funding for Pharmacy First and other Primary Care Access Recovery Plan services.

Keep ReadingShow less
New CPCF funding: “This is the best deal community pharmacy has had in a decade”

This new funding settlement marks a significant step forward in addressing the long term underinvestment in community pharmacy, says RPS England chair Tase Oputu

Pharmacy bodies hail new funding settlement as ‘best deal for community pharmacy in a decade’

Pharmacy bodies have welcomed the new funding settlement for community pharmacies, highlighting its potential to enhance patient access to care and medicines while addressing a decade of underinvestment in the sector.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a record £3.073 billion funding package for 2025/26, along with an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less